NCT00087425View on ClinicalTrials.gov

Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2007

Conditions

LeukemiaLymphoma

Interventions

BIOLOGICAL

rituximab

DRUG

bryostatin 1

Trial Locations (1)

20892-1182

NIH - Warren Grant Magnuson Clinical Center, Bethesda

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institute on Aging (NIA)

NIH

NCT00087425 - Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter